Arunjyoti Bio Ventures Limited

Financial Services · Finance

BSE: 530881
₹4.02
▼ -0.02 (-0.50%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
27/100
Weak
Valuation
68/100
Fairly Valued
Momentum
45/100
Neutral

QVM read Mixed signals Quality Weak, Valuation Fairly Valued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹75 Cr
PE (TTM)
Data unavailable.
Price to Book
2.6
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-87.3
Free Cash Flow
₹7 Cr
as of March 31, 2026
Industry median ₹-0 Cr (536 companies)
EPS Growth (YoY)
-163.64%
as of March 31, 2026
Industry median 25.00% (187 companies)
Net Profit Growth (TTM)
-37.70%
as of June 30, 2026
Industry median 0.00% (481 companies)
Operating Revenue Growth (TTM)
0.57%
as of June 30, 2026
Industry median 0.00% (476 companies)
Profit Growth (YoY)
-74.11%
as of June 30, 2026
Industry median 12.66% (188 companies)
Revenue Growth (YoY)
-5.88%
as of June 30, 2026
Industry median 8.05% (138 companies)
Current Ratio
0.43
as of March 31, 2026
Industry median 5.29 (212 companies)
Debt to Equity
0.76
as of March 31, 2026
Industry median 0.00 (206 companies)
Interest Coverage
-0.64
as of June 30, 2026
Industry median 2.05 (385 companies)
Net Margin
7.46%
as of June 30, 2026
Industry median 21.71% (183 companies)
Operating Margin (EBIT)
15.35%
as of June 30, 2026
Industry median 29.93% (192 companies)
Operating Margin (TTM)
-4.14%
as of June 30, 2026
Industry median 31.63% (395 companies)
Return on Assets
0.02%
as of March 31, 2026
Industry median 0.85% (493 companies)
Return on Capital Employed
-7.30%
as of March 31, 2026
Industry median 1.93% (197 companies)
Return on Equity
0.05%
as of March 31, 2026
Industry median 1.37% (491 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

1 of 6 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Debt to equity is below 0.5 (0.76)
  • No Return on equity is 15% or more (0.0%)
  • No Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

2 of 2 met
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

0 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

0 of 5 met
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-0.5%
Low 4.0100 · High 4.1800
1W return
-4.3%
Low 3.8000 · High 4.2300
1M return
-14.8%
Low 3.7800 · High 5.1000
52W return
-97.7%
Low 3.7800 · High 5.5400
Lifetime High ₹289.8000 (Jan. 15, 2024)
Lifetime Low ₹4.0100 (Sept. 28, 2026)

Full price history and technicals →

EMA & SMA

Bullish0
Bearish6
5D
4.1
10D
4.2
20D
6.0
50D
21.9
100D
53.0
200D
117.3

Delivery and volume

Day avg. delivery
93.6%
Week avg. delivery
88.1%
Month avg. delivery
77.3%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

4.07
Pivot
First resistance4.13
Second resistance4.24
Third resistance4.30
First support3.96
Second support3.90
Third support3.79
Day RSI35.0
Day MFI30.4
Day MACD-4.09
Day MACD signal-5.62

Beta

1M0.13
3M0.15
1Y0.15
3Y0.49

Price change analysis

↓ -14.8%
Over 1 Month
LowHigh
3.785.10
↓ -97.7%
Over 3 Months
LowHigh
3.785.54
↓ -97.7%
Over 6 Months
LowHigh
3.785.54
↓ -97.7%
Over 1 Year
LowHigh
3.785.54
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2026)
₹8 Cr
Net profit (June 30, 2026)
₹1 Cr
Basic EPS (June 30, 2026)
₹0.0300

Ranks #216 of 510 in Finance by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter47.64%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 47.64% in Jun 2026 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
16 Apr 2026 CHENNUPATI SARATH KUMAR Bulk Sell 2,379,657 10.5900 BSE
15 Apr 2026 CHENNUPATI SARATH KUMAR Bulk Sell 2,363,351 10.1800 BSE
9 Apr 2026 CHENNUPATI SARATH KUMAR Bulk Sell 1,158,401 8.8300 BSE
29 Aug 2025 MONIKA UDAY SHAH Bulk Sell 4,587,616 6.0000 BSE
29 Aug 2025 SHASHANK SAI PABBATHI Bulk Buy 4,590,000 6.0000 BSE
13 Dec 2024 P BADARI NARAYANA Bulk Sell 138,000 165.2000 BSE
29 Apr 2024 GLADISMENEZES Bulk Buy 15,000 59.9500 BSE
29 Apr 2024 GLADISMENEZES Bulk Sell 93,299 64.9900 BSE
29 Apr 2024 AMIT DHANYAKUMAR CHORDIA Bulk Buy 153,000 64.9900 BSE
6 Nov 2023 MADHUKAR SHETH Bulk Sell 12,069 195.6000 BSE

All bulk and block deals →

Corporate Actions

Full history (1 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from Century Twentyfirst Portfolio Ltd. to Arunjyoti Bio Ventures Limited

All corporate actions →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

  • Low Return on Equity (0.0%)
  • Tight liquidity (Current Ratio 0.43)
  • Declining revenue YoY (-5.9%)
  • Declining profit YoY (-74.1%)

Opportunities

Data unavailable.

Threats

  • Down 97.7% over the past year
  • Weak interest coverage (-0.6x) -- limited cushion against rising rates

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Arunjyoti Bio Ventures Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.